Federal Register of Legislation - Australian Government

Primary content

PB 104 of 2022 Determinations/Health as made
This instrument amends the National Health (Listed Drugs on F1 or F2) Determination 2021 by adding three new drugs, burosumab, cemiplimab and tepotinib, to F1.
Administered by: Health and Aged Care
Registered 31 Oct 2022
Tabling HistoryDate
Tabled HR07-Nov-2022
Tabled Senate21-Nov-2022
Date of repeal 08 Mar 2023
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Help with file formats Help with file formats
Legislative Instrument
F2022L01413 : Authoritative PDF Document : 0.6MB Primary Document Icon F2022L01413 : ZIP Document : 78KB
4 pages

Explanatory Statement
F2022L01413ES : PDF Document : 0.5MB Primary Document Icon F2022L01413ES : ZIP Document : 34KB
4 pages